Overview

Study of Tadalafil vs. Placebo for Improving Hemodynamics and End-Organ Dysfunction in Fontan Physiology

Status:
Recruiting
Trial end date:
2027-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out more about the effectiveness of Tadalafil in improving hemodynamic capabilities, endothelial function, and end-organ function in patients who have previously undergone a Fontan Palliation.
Phase:
Phase 3
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Tadalafil